HomeSiponimodSiponimod + Nonselective Beta Adrenergic Antagonists

Does Siponimod Interact with Nonselective Beta Adrenergic Antagonists?

Siponimod and Nonselective Beta Adrenergic Antagonists have a moderate drug interaction according to U.S. FDA drug labeling data. Caution when initiating siponimod in patients on beta-blockers; temporary interruption may be needed due to additive heart rate-lowering effects. The mechanism involves additive heart rate-lowering effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Siponimod Class
Sphingosine 1-phosphate Receptor Modulator
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Siponimod and Nonselective Beta Adrenergic Antagonists occurs because additive heart rate-lowering effects. Clinically, this means caution when initiating siponimod in patients on beta-blockers; temporary interruption may be needed due to additive heart rate-lowering effects. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Siponimod and your doctor is considering prescribing Nonselective Beta Adrenergic Antagonists (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Siponimod(Mayzent)+💊 Nonselective Beta Adrenergic Antagonists

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Sphingosine 1-phosphate Receptor Modulator
Drug B class
Source
NLP:siponimod

What this means in plain English

Caution when initiating siponimod in patients on beta-blockers; temporary interruption may be needed due to additive heart rate-lowering effects.

What the FDA label says

"Additive heart rate-lowering effects"

📖 Source: NLP:siponimod

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Siponimod and Nonselective Beta Adrenergic Antagonists against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.